The Saitohin 'Q7R' polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson's disease cohorts

Neuroscience Letters

Volumn 347, Issue 1, 2003, Pages 17-20

  Clark, Lorraine N ^a,c   Levy, Gilberto ^b   Tang, Ming Xin ^b   Mejia Santana, Helen ^b,c   Ciappa, Alejandra ^a,b   Tycko, Benjamin ^a   Cote, Lucien J ^c   Louis, Elan D ^b,c   Mayeux, Richard ^a,b,c   Marder, Karen ^a,b,c  

^a Columbia University ^*  (United States)

^b Vagelos College of Physicians and Surgeons   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Alzheimer's disease; Case control study; Multi ethnic; Parkinson's disease; Parkinson's disease with dementia; Saitohin; Tau haplotype

Indexed keywords

PROTEIN DERIVATIVE; SAITOHIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; ETHNIC DIFFERENCE; ETHNIC GROUP; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 0037966318     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00635-9     Document Type: Article

References (20)

1. Baker M., Litvan I., Houlden H., Adamson J., Dickson D., Perez-Tur J., Hardy J., Lynch T., Bigio E., Hutton M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 8:1999;711-715.
2. Bullido M.J., Aldudo J., Frank A., Coria F., Avila J., Valdivieso F. A polymorphism in the tau gene associated with risk for Alzheimer's disease. Neurosci. Lett. 278:2000;49-52.
3. Conrad C., Vianna C., Freeman M., Davies P. A polymorphic gene nested within an intron of the Tau gene: implications for Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 99:2002;7751-7756.
4. Cook L., Brayne C.E., Easton D., Grimley Evans J., Xuereb J., Cairns N.J., Rubinsztein D.C. No evidence for an association between Saitohin 'Q7R' polymorphism and Alzheimer's disease. Ann. Neurol. 52:2002;690-691.
5. De Silva R., Hardy J., Crook J., Khan N., Graham E.A., Morris C.M., Wood N.W., Lees A.J. The tau locus is not significantly associated with pathologically confirmed sporadic Parkinson's disease. Neurosci. Lett. 330:2002;201-203.
6. Farrer M., Skipper L., Berg M., Bisceglio G., Hanson M., Hardy J., Adam A., Gwinn-Hardy K., Aasly J. The tau H1 haplotype is associated with Parkinson's disease in the Norwegian population. Neurosci. Lett. 322:2002;83-86.
7. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31:1990;545-548.
8. Hoenicka J., Perez M., Perez-Tur J., Barabash A., Godoy M., Vidal B.S., Astarloa R., Avila J., Nygaard T., de Yebenes J.G. The tau gene A0 allele and progressive supranuclear palsy. Neurology. 53:1999;1219-1225.
9. Lilius L., Froelich Fabre S., Basun H., Forsell C., Axelman K., Mattila K., Andreadis A., Vitanen M., Winblad B., Fratiglioni L., Lannfelt L. Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease. Neurosci. Lett. 277:1999;29-32.
10. Maestre G., Ottman R., Stern Y., Gurland B., Chun M., Tang M.X., Shelanski M., Tycko B., Mayeux R. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann. Neurol. 37:1995;254-259.
11. Marder K., Tang M.X., Cote L., Stern Y., Mayeux R. The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch. Neurol. 52:1995;695-701.
12. Mayeux R., Denaro J., Hemengildo N., Marder K., Tang M.X., Cote L.J., Stern Y. A population based investigation of Parkinson's disease with and without dementia. Arch. Neurol. 49:1992;492-497.
13. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., Salmon D.P., Lowe J., Mirra S.S., Byrne E.J., Lennox G., Quinn N.P., Edwardson J.A., Ince P.G., Bergeron C., Burns A., Miller B.L., Lovestone S., Collerton D., Jansen E.N., Ballard C., de Vos R.A., Wilcock G.K., Jellinger K.A., Perry R.H. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 47:1996;1113-1124.
14. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
15. Pastor P., Ezquerra M., Munoz E., Marti M.J., Blesa R., Tolosa E., Oliva R. Significant association between the tau gene A0/A0 genotype and Parkinson's disease. Ann. Neurol. 47:2000;242-245.
16. Russ C., Powell J.F., Zhao J., Baker M., Hutton M., Crawford F., Mullan M., Roks G., Cruts M., Lovestone S. The microtubule associated protein Tau gene and Alzheimer's disease - an association study and meta-analysis. Neurosci. Lett. 314:2001;92-96.
17. Stern Y., Andrews H., Pittman J., Sano M., Tatemichi T., Lantigua R., Mayeux R. Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch. Neurol. 49:1992;453-460.
18. Streffer J.R., Papassotiropoulos A., Kurosinski P., Signorell A., Wollmer M.A., Tsolaki M., Iakovidou V., Horndli F., Bosset J., Gotz J., Nitsch R.M., Hock C. Saitohin gene is not associated with Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 74:2003;362-363.
19. Tang M.X., Stern Y., Marder K., Bell K., Gurland B., Lantigua R., Andrews H., Feng L., Tycko B., Mayeux R. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, Whites, and Hispanics. J. Am. Med. Assoc. 279:1998;751-755.
20. Verpillat P., Ricard S., Hannequin D., Dubois B., Bou J., Camuzat A., Pradier L., Frebourg T., Brice A., Clerget-Darpoux F., Deleuze J.-F., Campion D. Is the Saitohin gene involved in neurodegenerative diseases? Ann. Neurol. 52:2002;829-832.